Stuurman DC - Search Results

1

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.

Feijtel D, Reuvers TGA, van Tuyll-van Serooskerken C, de Ridder CMA, Stuurman DC, de Blois E, Verkaik NS, de Bruijn P, Koolen SLW, de Jong M, Nonnekens J. Feijtel D, et al. Among authors: stuurman dc. Cancers (Basel). 2023 Feb 1;15(3):915. doi: 10.3390/cancers15030915. Cancers (Basel). 2023. PMID: 36765883 Free PMC article.

2

High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.

Marques RB, Aghai A, de Ridder CMA, Stuurman D, Hoeben S, Boer A, Ellston RP, Barry ST, Davies BR, Trapman J, van Weerden WM. Marques RB, et al. Eur Urol. 2015 Jun;67(6):1177-1185. doi: 10.1016/j.eururo.2014.08.053. Epub 2014 Sep 12. Eur Urol. 2015. PMID: 25220373

3

Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model.

Mout L, de Wit R, Stuurman D, Verhoef E, Mathijssen R, de Ridder C, Lolkema M, van Weerden W. Mout L, et al. EBioMedicine. 2018 Jan;27:182-186. doi: 10.1016/j.ebiom.2017.12.024. Epub 2017 Dec 20. EBioMedicine. 2018. PMID: 29276148 Free PMC article.

4

In Vivo Evaluation of Indium-111-Labeled 800CW as a Necrosis-Avid Contrast Agent.

Stroet MCM, de Blois E, Stuurman DC, de Ridder CMA, Haeck J, Seimbille Y, Mezzanotte L, de Jong M, Löwik CWGM, Panth KM. Stroet MCM, et al. Among authors: stuurman dc. Mol Imaging Biol. 2020 Oct;22(5):1333-1341. doi: 10.1007/s11307-020-01511-x. Mol Imaging Biol. 2020. PMID: 32514888 Free PMC article.

5

Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.

Mout L, Moll JM, Chen M, de Morrée ES, de Ridder CMA, Gibson A, Stuurman D, Aghai A, Erkens-Schulze S, Mathijssen RHJ, Sparreboom A, de Wit R, Lolkema MP, van Weerden WM. Mout L, et al. Br J Cancer. 2020 Dec;123(12):1715-1719. doi: 10.1038/s41416-020-01105-y. Epub 2020 Sep 29. Br J Cancer. 2020. PMID: 32989230 Free PMC article.

6

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.

Ruigrok EAM, van Vliet N, Dalm SU, de Blois E, van Gent DC, Haeck J, de Ridder C, Stuurman D, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: stuurman d. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1339-1350. doi: 10.1007/s00259-020-05057-6. Epub 2020 Oct 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33094433 Free PMC article.

7

Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

van de Merbel AF, van der Horst G, van der Mark MH, Bots STF, van den Wollenberg DJM, de Ridder CMA, Stuurman D, Aalders T, Erkens-Schulz S, van Montfoort N, Karthaus WR, Mehra N, Smits M, Schalken JA, van Weerden WM, Hoeben RC, van der Pluijm G. van de Merbel AF, et al. Cancer Gene Ther. 2022 Jun;29(6):793-802. doi: 10.1038/s41417-021-00360-2. Epub 2021 Jun 16. Cancer Gene Ther. 2022. PMID: 34135475 Free PMC article.

8

Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer.

Mout L, van Royen ME, de Ridder C, Stuurman D, van de Geer WS, Marques R, Buck SAJ, French PJ, van de Werken HJG, Mathijssen RHJ, de Wit R, Lolkema MP, van Weerden WM. Mout L, et al. EBioMedicine. 2021 Nov;73:103681. doi: 10.1016/j.ebiom.2021.103681. Epub 2021 Nov 5. EBioMedicine. 2021. PMID: 34749299 Free PMC article.

9

The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo.

Klomp MJ, Hofland LJ, van den Brink L, van Koetsveld PM, Dogan F, de Ridder CMA, Stuurman DC, Clahsen-van Groningen MC, de Jong M, Dalm SU. Klomp MJ, et al. Among authors: stuurman dc. Pharmaceutics. 2022 Jan 12;14(1):173. doi: 10.3390/pharmaceutics14010173. Pharmaceutics. 2022. PMID: 35057069 Free PMC article.

10

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.

Ruigrok EAM, Verkaik NS, de Blois E, de Ridder C, Stuurman D, Roobol SJ, Van Gent DC, de Jong M, Van Weerden WM, Nonnekens J. Ruigrok EAM, et al. Among authors: stuurman d. Int J Mol Sci. 2022 Jul 21;23(14):8037. doi: 10.3390/ijms23148037. Int J Mol Sci. 2022. PMID: 35887398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page